Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 444 record(s)

Req # A-2023-000118

Adverse Drug Reactions (ADRs). Report numbers: E2B_05944994, E2B_05940602, E2B_05949595, 001016246, E2B_04797500, E2B_03744335, 001016116, E2B_05906235, 001019162, E2B_05887214.

Organization: Health Canada

117 page(s)
July 2023

Req # A-2023-000120

Adverse Drug Reactions (ADRs) for Temodal. Report numbers: E2B_02972537, E2B_02329756, E2B_02972917, E2B_02132593, E2B_02131525, E2B_00718444, E2B_02398784.

Organization: Health Canada

355 page(s)
July 2023

Req # A-2023-000133

Adverse Drug Reaction (ADR). Report number: E2B_06151603.

Organization: Health Canada

18 page(s)
July 2023

Req # A-2023-000141

Adverse Drug Reaction (ADR). Report number: E2B_06143113.

Organization: Health Canada

14 page(s)
July 2023

Req # A-2023-000142

Adverse Drug Reactions (ADRs). Report numbers: E2B_05626567, E2B_06091610.

Organization: Health Canada

29 page(s)
July 2023

Req # A-2023-000144

Adverse Drug Reactions (ADRs). Report numbers: 001012008, E2B_05973298, 001017661, E2B_05771578, 001010359, E2B_05968917, E2B_05970251, E2B_05785121.

Organization: Health Canada

75 page(s)
July 2023

Req # A-2023-000145

Adverse Drug Reactions (ADRs). Report numbers: 000960475, 000970044, E2B_04193198, E2B_04318483, E2B_04476673, E2B_04477019, E2B_04551382, E2B_04608126, 000967445, 000975140.

Organization: Health Canada

141 page(s)
July 2023

Req # A-2023-000161

Adverse Drug Reactions (ADRs) for TEMODAL. Report numbers: E2B_03072550, E2B_02069473, E2B_02600423, E2B_02839770, E2B_03200196.

Organization: Health Canada

75 page(s)
July 2023

Req # A-2023-000163

Adverse Drug Reactions (ADRs) for ENTYVIO. Report numbers: E2B_06130187, E2B_06181182, E2B_06183045. ADRs for ONDANSETRON. Report numbers: 001031515, E2B_06197292, E2B_06120653. ADRs for PANTOPRAZOLE SODIUM. Report numbers: E2B_06138078, E2B_06148267, 001028218, 001039328.

Organization: Health Canada

464 page(s)
July 2023

Req # A-2023-000174

Adverse Drug Reactions (ADRs). Report numbers: 001007986, E2B_06132172.

Organization: Health Canada

13 page(s)
July 2023
Date modified: